Literature DB >> 22126553

Risk of malignancy index in preoperative evaluation of pelvic masses.

Tahereh Ashrafgangooei1, Mahdieh Rezaeezadeh.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the use of risk of malignancy index (RMI) based on a serum CA125 level, ultrasound findings and menopausal status in primary evaluation of patients with adnexal masses in daily clinical practice.
METHODS: One hundred and fifty one women with adnexal masses were enrolled. Ultrasound characteristics, menopausal status and serum CA125 level were documented preoperatively, and combined into the RMI afterwards. The sensitivity, specificity, positive (PPV) and negative predictive values (NPV) of the RMI in prediction of ovarian cancer were calculated.
RESULTS: The RMI identified malignant cases more accurately than any individual criterion in diagnosing ovarian cancer. Using a cut-off level of 238 to indicate malignancy, the RMI showed a sensitivity of 89.5%, a specificity of 96.2%, a PPV of 77.3%, a NPV of 98.4% and an accuracy of 95.4%.
CONCLUSION: RMI is a simple, easily applicable method in the primary evaluation of patients with adnexal masses of high risk of malignancy, resulting in timely referal to gynecological oncology centers for suitable surgical operations.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22126553

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

1.  Current diagnostic approach to patients with adnexal masses: which tools are relevant in routine praxis?

Authors:  Milan M Terzic; Jelena Dotlic; Ivana Likic; Nebojsa Ladjevic; Natasa Brndusic; Nebojsa Arsenovic; Sanja Maricic; Tihomir Mihailovic; Sasa Andrijasevic
Journal:  Chin J Cancer Res       Date:  2013-02       Impact factor: 5.087

2.  Is Risk Malignancy Index a Useful Tool for Predicting Malignant Ovarian Masses in Developing Countries?

Authors:  Aliya B Aziz; Nida Najmi
Journal:  Obstet Gynecol Int       Date:  2015-06-21

3.  A prospective study to evaluate the risk malignancy index and its diagnostic implication in patients with suspected ovarian mass.

Authors:  Santosh Kumar Dora; Atal Bihari Dandapat; Benudhar Pande; Jatindra Prasad Hota
Journal:  J Ovarian Res       Date:  2017-08-14       Impact factor: 4.234

4.  Can Replacing CA125 with HE4 in Risk of Malignancy Indices 1-4 Improve Diagnostic Performance in the Presurgical Assessment of Adnexal Tumors?

Authors:  Nabil Abdalla; Robert Piórkowski; Paweł Stanirowski; Krzysztof Cendrowski; Włodzimierz Sawicki
Journal:  Biomed Res Int       Date:  2017-11-07       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.